Tatva Chintan Pharma Chem Ltd
NSE :TATVA BSE :543321 Sector : ChemicalsBuy, Sell or Hold TATVA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
24 Dec 851.90 (4.79%) | 23 Dec 812.95 (-3.58%) | 20 Dec 843.15 (-1.64%) | 19 Dec 857.20 (-0.75%) | 18 Dec 863.70 (-1.66%) | 17 Dec 878.30 (0.18%) | 16 Dec 876.70 (-1.09%) | 13 Dec 886.40 (-1.84%) | 12 Dec 903.05 (-0.04%) | 11 Dec 903.45 (0.38%) | 10 Dec 900.00 (0.08%) | 09 Dec 899.30 (0.47%) | 06 Dec 895.10 (0.33%) | 05 Dec 892.15 (0.02%) | 04 Dec 892.00 (1.80%) | 03 Dec 876.20 (0.81%) | 02 Dec 869.15 (-1.85%) | 29 Nov 885.50 (-1.07%) | 28 Nov 895.05 (4.23%) | 27 Nov 858.70 (1.80%) | 26 Nov 843.50 (2.39%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Very Bearish
Moving Averages
5 DMA
Bullish
845.87
10 DMA
Bearish
867.68
20 DMA
Bearish
877.14
50 DMA
Bearish
882.69
100 DMA
Bearish
938.35
200 DMA
Bearish
1038
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Dec 24, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 918.94 | 891.97 | 864.83 | - | - |
R2 | 891.97 | 874.02 | 860.52 | 893.7 | - |
R1 | 871.94 | 862.92 | 856.21 | 875.4 | 881.95 |
P | 844.97 | 844.97 | 844.97 | 846.7 | 849.98 |
S1 | 824.94 | 827.02 | 847.59 | 828.4 | 834.95 |
S2 | 797.97 | 815.92 | 843.28 | 799.7 | - |
S3 | 777.94 | 797.97 | 838.98 | - | - |
Key Metrics
EPS
5.68
P/E
149.65
P/B
2.76
Dividend Yield
0.24%
Market Cap
1,993 Cr.
Face Value
10
Book Value
308.43
ROE
4.85%
EBITDA Growth
4.96 Cr.
Debt/Equity
0.15
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Tatva Chintan Pharma Chem Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 97.43 | 85.42 | 102.79 | 106.64 | 83.87 | |
PROFIT | 7.78 | 3.46 | 9.61 | 5.21 | -0.66 | |
EPS | 3.43 | 1.48 | 4.11 | 2.23 | -0.29 |
Tatva Chintan Pharma Chem Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 93.33 | 87.28 | 98.46 | 95.23 | 81.77 | |
PROFIT | 8.2 | 4.65 | 8.25 | 1.51 | -1.11 | |
EPS | 3.63 | 1.99 | 3.52 | 0.64 | -0.47 |
Profit & Loss (Figures in Rs. Crores)
Tatva Chintan Pharma Chem Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 140.37 | 211.88 | 280.46 | 309.62 | 506.07 | 423.64 | 409.19 | |
PROFIT | 12.28 | 19.98 | 37.82 | 52.29 | 95.91 | 48.75 | 30.41 | |
EPS | 0 | 0 | 0 | 0 | 43.25 | 20.52 | 12.98 |
Tatva Chintan Pharma Chem Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 136.92 | 207.2 | 270.43 | 301.49 | 496.48 | 402.21 | 396.91 | |
PROFIT | 11.05 | 19.62 | 34.98 | 51.39 | 96.03 | 43.78 | 29.41 | |
EPS | 13.74 | 25.12 | 43.51 | 25.57 | 43.31 | 18.26 | 12.55 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 23.39 | 22.17 | 22.17 | 20.09 | 8.04 | 8.04 | 8.04 |
Reserves Total | 713.69 | 492.63 | 450.92 | 145.88 | 109.66 | 71.67 | 51.08 |
Total Shareholders Funds | 737.08 | 514.8 | 473.09 | 165.97 | 117.7 | 79.71 | 59.12 |
Secured Loans | 14.27 | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Total Debt | 14.27 | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Other Liabilities | 1.33 | 1.15 | 0.67 | 1.98 | 0.43 | 0.33 | 0.16 |
Total Liabilities | 752.68 | 686.21 | 593.7 | 258.2 | 208.82 | 157.19 | 115.43 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 488.02 | 231.78 | 186.14 | 138.88 | 122.48 | 73.46 | 59.99 |
Less: Accumulated Depreciation | 61.14 | 35.53 | 26.53 | 18.44 | 11.3 | 6.74 | 2.95 |
Net Block | 426.88 | 196.25 | 159.61 | 120.44 | 111.18 | 66.72 | 57.04 |
Capital Work in Progress | 76.54 | 230.74 | 51.49 | 9.81 | 4.89 | 6.04 | 9.94 |
Investments | 10.05 | 0 | 0 | 0 | 0 | 0 | 0.53 |
Inventories | 152.77 | 162.5 | 169.96 | 72.02 | 63.56 | 35.59 | 28.82 |
Sundry Debtors | 69.85 | 84.4 | 56.6 | 90.74 | 49.57 | 41.26 | 28.81 |
Cash and Bank Balance | 38.29 | 44.76 | 176.99 | 5.34 | 10.83 | 15.75 | 7.76 |
Loans and Advances | 26.94 | 20.59 | 32.35 | 16.15 | 8.74 | 21.79 | 10.59 |
Total Current Assets | 287.85 | 312.25 | 435.89 | 184.25 | 132.7 | 114.38 | 75.97 |
Current Liabilities | 65.59 | 72.12 | 63.41 | 54.03 | 35.61 | 26.99 | 26.65 |
Provisions | 0.44 | 0.55 | 1.2 | 0.5 | 0.06 | 0.04 | 0.03 |
Total Current Liabilities & Provisions | 66.03 | 72.67 | 64.61 | 54.53 | 35.67 | 27.03 | 26.68 |
Net Current Assets | 221.82 | 239.59 | 371.28 | 129.72 | 97.02 | 87.35 | 49.29 |
Deferred Tax Assets | 39.44 | 29.06 | 19.65 | 7.22 | 1.35 | 0.15 | 0.69 |
Deferred Tax Liability | 27.14 | 12.66 | 10.94 | 9.3 | 5.8 | 3.45 | 2.3 |
Net Deferred Tax | 12.3 | 16.4 | 8.71 | -2.08 | -4.45 | -3.3 | -1.61 |
Other Assets | 5.09 | 3.21 | 2.6 | 0.3 | 0.17 | 0.38 | 0.23 |
Total Assets | 752.68 | 686.19 | 593.69 | 258.2 | 208.81 | 157.18 | 115.42 |
Contingent Liabilities | 1.32 | 1.46 | 3.34 | 0.51 | 0.7 | 0 | 0.41 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 23.39 | 22.17 | 22.17 | 20.09 | 8.04 | 8.04 | 8.04 |
Reserves Total | 702.49 | 482.62 | 446.71 | 141.85 | 106.41 | 71.6 | 51.45 |
Total Shareholders Funds | 725.88 | 504.79 | 468.88 | 161.94 | 114.45 | 79.64 | 59.49 |
Secured Loans | 14.27 | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Total Debt | 14.27 | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Other Liabilities | 1.33 | 1.15 | 0.66 | 1.98 | 0.43 | 0.33 | 0.16 |
Total Liabilities | 741.48 | 676.2 | 589.48 | 254.17 | 205.57 | 157.12 | 115.8 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 488 | 231.75 | 186.14 | 138.88 | 122.48 | 73.45 | 59.98 |
Less : Accumulated Depreciation | 61.13 | 35.53 | 26.53 | 18.43 | 11.3 | 6.74 | 2.95 |
Net Block | 426.87 | 196.22 | 159.61 | 120.45 | 111.18 | 66.71 | 57.03 |
Capital Work in Progress | 76.54 | 230.74 | 51.49 | 9.81 | 4.89 | 6.04 | 9.94 |
Investments | 10.72 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 1.2 |
Inventories | 144.11 | 151.45 | 160.69 | 68.36 | 58.72 | 31.06 | 25.75 |
Sundry Debtors | 67.95 | 90.04 | 61.6 | 90.34 | 50.97 | 44.65 | 32.88 |
Cash and Bank Balance | 36.97 | 38.58 | 174.74 | 3.59 | 9.82 | 15.67 | 7.17 |
Loans and Advances | 34.52 | 27.54 | 56.09 | 16.18 | 8.89 | 22.2 | 10.46 |
Total Current Assets | 283.55 | 307.61 | 453.12 | 178.47 | 128.4 | 113.57 | 76.25 |
Current Liabilities | 73.22 | 78.34 | 86.36 | 53.24 | 35.22 | 26.91 | 27.23 |
Provisions | 0.36 | 0.33 | 0.37 | 0.2 | 0.06 | 0.04 | 0.03 |
Total Current Liabilities & Provisions | 73.58 | 78.67 | 86.73 | 53.44 | 35.29 | 26.94 | 27.25 |
Net Current Assets | 209.97 | 228.94 | 366.39 | 125.03 | 93.11 | 86.63 | 49 |
Deferred Tax Assets | 39.44 | 29.06 | 19.65 | 7.22 | 1.35 | 0.15 | 0.69 |
Deferred Tax Liability | 27.14 | 12.66 | 10.94 | 9.3 | 5.8 | 3.45 | 2.3 |
Net Deferred Tax | 12.3 | 16.4 | 8.71 | -2.08 | -4.45 | -3.3 | -1.61 |
Other Assets | 5.09 | 3.21 | 2.6 | 0.3 | 0.17 | 0.38 | 0.23 |
Total Assets | 741.49 | 676.19 | 589.47 | 254.18 | 205.57 | 157.12 | 115.8 |
Contingent Liabilities | 1.32 | 1.46 | 3.34 | 0.51 | 0.68 | 0.43 | 0 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 43.57 |
Depreciation | 25.61 |
Interest (Net) | 3.26 |
P/L on Sales of Invest | -0.04 |
P/L in Forex | -0.38 |
Total Adjustments (PBT and Ext... | 28.6 |
Operating Profit before Workin... | 72.17 |
Trade and 0ther Receivables | 15.39 |
Inventories | 9.73 |
Trade Payables | 11.25 |
Total Adjustments (OP before W... | 35.73 |
Cash Generated from/(used in) ... | 107.9 |
Direct Taxes Paid | -9.86 |
Total Adjustments(Cash Generat... | -9.86 |
Cash Flow before Extraordinary... | 98.04 |
Net Cash from Operating Activi... | 98.04 |
Purchased of Fixed Assets | -128.52 |
Sale of Fixed Assets | 0.16 |
Purchase of Investments | -9.9 |
Sale of Investments | 0.04 |
Interest Received | 3.27 |
Net Cash used in Investing Act... | -120.62 |
Proceeds from Issue of shares ... | 196.6 |
Of the Long Tem Borrowings | -8.66 |
Of the Short Term Borrowings | -146.21 |
Dividend Paid | -4.68 |
Interest Paid | -6.53 |
Net Cash used in Financing Act... | 30.52 |
Net Profit before Tax and Extr... | 42.27 |
Depreciation | 25.6 |
Interest (Net) | 3.23 |
P/L on Sales of Invest | -0.04 |
P/L in Forex | -0.59 |
Total Adjustments (PBT and Ext... | 28.17 |
Operating Profit before Workin... | 70.44 |
Trade and 0ther Receivables | 22.56 |
Inventories | 7.34 |
Trade Payables | 11.21 |
Total Adjustments (OP before W... | 40.58 |
Cash Generated from/(used in) ... | 111.02 |
Direct Taxes Paid | -8.24 |
Total Adjustments(Cash Generat... | -8.24 |
Cash Flow before Extraordinary... | 102.78 |
Net Cash from Operating Activi... | 102.78 |
Purchased of Fixed Assets | -128.52 |
Sale of Fixed Assets | 0.16 |
Purchase of Investments | -9.9 |
Sale of Investments | 0.04 |
Interest Received | 3.27 |
Net Cash used in Investing Act... | -120.52 |
Proceeds from Issue of shares ... | 196.6 |
Of the Long Tem Borrowings | -8.66 |
Of the Short Term Borrowings | -146.21 |
Dividend Paid | -4.68 |
Interest Paid | -6.51 |
Net Cash used in Financing Act... | 30.54 |
Company Details
Registered Office |
|
Address | No 502/17 GIDC Estate, Ankleshwar |
City | Bharuch |
State | Gujarat |
Pin Code | 393002 |
Tel. No. | +91-75730-46951/46952 |
Fax. No. | |
cs@tatvachintan.com | |
Internet | http://www.tatvachintan.com |
Registrars |
|
Address | No 502/17 GIDC Estate |
City | Bharuch |
State | Gujarat |
Pin Code | 393002 |
Tel. No. | +91-75730-46951/46952 |
Fax. No. | |
cs@tatvachintan.com | |
Internet | http://www.tatvachintan.com |
Management |
|
Name | Designation |
Chintan Nitinkumar Shah | Chairman & Managing Director |
Ajaykumar Mansukhlal Patel | Whole-time Director |
Shekhar Rasiklal Somani | Whole-time Director |
Subhash Patel | Independent Non Exe. Director |
Avani Rajesh Umatt | Independent Non Exe. Director |
Manher Chinmanlal Desai | Independent Non Exe. Director |
Ishwar Nayi | Company Sec. & Compli. Officer |